Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Posted on by Pencis

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

ORCID ID

šŸ“šEARLY ACADEMIC PURSUITSĀ 

ZENG QINGJUN completed his Masterā€™s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

āš•ļøPROFESSIONAL ENDEAVORSĀ 

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

šŸ”¬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

šŸŒIMPACT AND INFLUENCEĀ 

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

šŸ“‘ACADEMIC CITATIONSĀ 

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

šŸŒ±LEGACY AND FUTURE CONTRIBUTIONSĀ 

Dr. ZENG QINGJUNā€™s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

šŸ’¼LEADERSHIP IN SURGICAL PRACTICEĀ 

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

šŸ”— CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

šŸ“ŠšŸ”¬NOTABLE PUBLICATION:
  • 1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
    Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
    Journal: Cancer Biotherapy and Radiopharmaceuticals
    Year: 2023

    2. Title: Targeting of MAD2L1 by miRā€515ā€5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
    Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
    Journal: Cell Biology International
    Year: 2022

Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Posted on by Pencis

Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award

Chongqing Medical University | China

Author Profile

Scopus

ORCID ID

Professor Yinyuan Ding

šŸŒŸ Professor of Oncology
šŸ„ Chongqing Medical University

šŸŽ“ Academic and Professional Background:

Professor Yinyuan Ding obtained a Ph.D. from Peking University in 2011 and pursued postdoctoral training at UT Southwestern Medical Center, where he was later promoted to Assistant Professor in 2018. In 2019, he returned to China and joined Chongqing Medical University as a professor. His research explores tumorigenesis and glucolipid metabolic disorders, focusing on the LRP1 receptor’s role in liver and vascular signaling, with implications for novel treatments for Hepatocellular Carcinoma (HCC) and Metabolic Associated Steatohepatitis-Liver Disease (MASLD).

šŸ”¬ Research and Innovations:

  • Principal Investigator
    2023-2026: “The role of LRP1 in hepatic glucose metabolism and HCC progression” (National Natural Science Foundation of China)
    2021: “The role of Asprosin in hepatocellular carcinoma” (Chongqing Municipal Human Resources Bureau)

 

  • Participant
    2015-2020: “VLDL and ApoE receptors metabolism” (NIH-NHLBI)
    2011-2015: “Cell signaling and cholesterol-lipoprotein receptors” (NIH)

šŸ“š Journals Published:

Advanced Science, Elife, Science Signaling, EBioMedicine, JBC

šŸ¤ Collaborations:

Collaborates with Joachim Herz (UT Southwestern Medical Center, USA)

šŸ‘„ Professional Memberships:

Director of the China Branch, International Atherosclerosis Society

šŸ§¬ Areas of Research:

  • Oncology
  • Tumorigenesis
  • Hepatology
  • Lipoprotein & Lipid Research

šŸ“ Contributions:

Professor Ding’s groundbreaking research on LRP1 has revealed its multifaceted roles in regulating cholesterol and glucose metabolism. His work identified a critical mechanism by which LRP1 affects hepatic insulin resistance, dyslipidemia, and HCC progression. This novel insight into LRP1’s function opens pathways for innovative therapeutic strategies for cancer and metabolic disorders.

āœØConclusion:

In summary, Professor Yinyuan Ding is a distinguished expert in oncology and hepatology, with a strong focus on the molecular mechanisms of tumorigenesis and lipid metabolism disorders. His innovative research on LRP1 has led to significant breakthroughs in understanding liver disease and cancer progression, paving the way for novel therapeutic strategies. With a wealth of experience from top institutions and numerous prestigious publications and patents, Professor Ding continues to make impactful contributions to the field of cancer research, driving advancements in both basic science and clinical applications. šŸŒŸ

šŸ“ŠšŸ”¬NOTABLE PUBLICATION:

1. LRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD-fed mice

  • Authors: Guo, X., Pu, J., Tang, Z., Liu, T., Ding, Y.
  • Journal: Animal Models and Experimental Medicine
  • Year: 2024

2. Erratum: Correction: LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis

  • Authors: Xian, X., Ding, Y., Dieckmann, M., Tsai, S., Herz, J.
  • Journal: eLife
  • Year: 2017 (Erratum published in 2024)

3. Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-ĪŗB Signaling

  • Authors: Guo, X., Yang, F., Liu, T., Herz, J., Ding, Y.
  • Journal: Advanced Science
  • Year: 2024

Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Posted on by Pencis

Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Baotou Medical College of Inner Mongolia University of Science and Technology | China

Author Profile

ORCID Id

šŸ‘©ā€āš•ļøšŸ’‰Xiaorong Zhu: Aspiring Internal Medicine PhysicianĀ 

šŸŽ“ Education Experience

  • šŸŽ“2016.09-2021.07: Bachelor’s in Clinical Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology
  • šŸ„2021.09-2024.07: Master’s in Internal Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology

šŸ©ŗ Internship Experience

  • šŸØ2019.08-2021.07: Baotou City Central Hospital (Fieldwork)
    • šŸ„Completed rotations in Internal Medicine, Surgery, Obstetrics & Gynecology, and Emergency Department.
    • āš•ļøGained practical experience diagnosing and treating common diseases.
  • šŸ©ŗ2021.09-2024.07: Baotou City Central Hospital (Resident Training)
    • šŸ’‰Participated in over 100 clinical cases, working closely with senior physicians.
    • šŸ”¬Skilled in bone marrow punctures, biopsies, and other key clinical procedures.

šŸŽÆ School Experience

  • šŸŽ“2016.09-2021.07: Undersecretary, Student Union of Central Clinical Medical School
    • šŸ“šOrganized medical seminars, attracting over 200 participants.
    • šŸ©ŗšŸ‘©ā€āš•ļøCoordinated clinical skills workshops, helping 100 students improve their skills.
    • šŸ¤šŸ’”Led volunteer projects, involving 300 student volunteers.

šŸ† Relevant Skills

  • šŸ“œCertified in Standardized Resident Training (Internal Medicine)
  • šŸ“–Fluent in English (CET-4), with strong reading and writing abilities
  • āœļøHolder of Internal Medicine Qualification & Registration Certificates

šŸŒŸ Xiaorong Zhu is a dedicated physician in training, passionate about advancing patient care and mastering clinical skills in Internal Medicine. šŸŒæšŸ‘©ā€āš•ļø

āœØConclusionšŸŽÆ

šŸ‘©ā€āš•ļøIn summary, Xiaorong Zhu is a driven and skilled emerging physician with a strong foundation in Clinical Medicine and Internal Medicine. With hands-on experience in diverse medical fields, including rotations and resident training at Baotou City Central Hospital, she has developed expertise in clinical diagnosis and advanced procedures like bone marrow biopsies. Her leadership roles in academic and volunteer initiatives further demonstrate her dedication to the medical field and commitment to improving patient care. As Xiaorong continues her journey, she is poised to make significant contributions to the healthcare community. šŸŒŸšŸ’‰.

 

šŸ“ŠšŸ”¬NOTABLE PUBLICATION:

 

    • Function of NLRP3 inflammasome activation in multiple myeloma
      • Authors: Xiaorong Zhu, Jie Yu, Mingqiang Hua, Ning Xu, Lianjuan Wang, Lingkai Chen, Yanhong Jia, Xueyun Zhao
        Journal: Hematology
        Year: 2024

Dr. Abdulhadi Aljawish | Cytotoxicity | Best Researcher Award

Posted on by Pencis

Dr. Abdulhadi Aljawish | Cytotoxicity | Best Researcher Award

National Conservatory of Arts and Crafts | France

Author Profile

Scopus

Google Scholar

Biography: Dr. Abdulhadi ALJAWISH

šŸ§‘ā€šŸ”¬ Education

2009-2013: Ph.D. in Biotechnological and Food Processes (with Honors)
Laboratoire dā€™IngĆ©nierie des BiomolĆ©cules-ENSAIA, UniversitĆ© de Lorraine, Nancy, France
Thesis: “Enzymatic functionalization of chitosan with phenolic compounds by Myceliophthora thermophila laccase”
Advisors: Prof. Joƫl SCHER, Prof. Isabelle CHEVALOT
Defense Date: 08/07/2013

2008-2009: Masterā€™s in Biotechnology, Agro-resources, Food, Nutrition (B.A.A.N) (with Merit)
Laboratoire de Biocatalyse-BioprocƩdƩs (LBB), ENSAIA-INPL, Nancy, France
Research: “Enzymatic synthesis of natural colorants from phenolic compounds”
Advisors: Prof. Michel GIRARDIN, Dr. Lionel MUNIGLIA

šŸ‘Øā€šŸ’¼ Professional Experience

2021-2023: Head of Research & Development in Enzymatic Processes
SAS GECCO, Institut Charles VIOLLETTE – Laboratoire des ProcĆ©dĆ©s Biologiques, GĆ©nie Enzymatique et Microbien (ProBioGem), UniversitĆ© de Lille, Lille, France

2019-2021: Research & Development Engineer in Enzymatic Processes
SAS GECCO, Institut Charles VIOLLETTE – Laboratoire des ProcĆ©dĆ©s Biologiques, GĆ©nie Enzymatique et Microbien (ProBioGem), UniversitĆ© de Lille, Lille, France

2016-2018: Postdoctoral Fellow in Biocatalysis – Bioprocesses
Institut Charles VIOLLETTE – Laboratoire des ProcĆ©dĆ©s Biologiques, GĆ©nie Enzymatique et Microbien (ProBioGem), UniversitĆ© de Lille, Lille, France

2015-2016: Postdoctoral Fellow in Biochemistry – Toxicology
Institut de Chimie MolƩculaire (ICMUB-UMR-CNRS6302), UniversitƩ de Bourgogne, Dijon, France
Laboratoire de Nutrition et Toxicologie (NuTox), INSERM -UMR U866-Agrosup, Dijon, France

2013-2015: Temporary Teaching and Research AttachĆ© (ATER) in Biochemistry ā€“ Food Biotechnology
Ɖcole nationale supĆ©rieure d’agronomie et des industries alimentaires (ENSAIA), UniversitĆ© de Lorraine, Nancy, France

2009-2013: Ph.D. Researcher in Biotechnology and Food Processes
Laboratoire dā€™IngĆ©nierie des BiomolĆ©cules (LIBio), Laboratoire RĆ©actions et GĆ©nie des procĆ©dĆ©s (LRGP)-ENSAIA, UniversitĆ© de Lorraine, Nancy, France

šŸ“š Supervision and Collective Responsibilities

  • Supervised several Masterā€™s and Ph.D. students in various projects related to enzymatic purification, functionalization, and biotests development.
  • Managed projects on the valorization of food waste and biodiesel by-products, emphasizing circular economy principles.

šŸ§¬ Skills and Expertise

  • Circular Economy: Valorization of food waste and biomass, biodiesel production, energy recovery.
  • Biosynthesis/Biocatalysis: Enzyme purification and characterization, oxidative processes, esterification, transesterification, kinetic studies, various enzymes like lipase, polyphenol oxidases, cellulase, amidase, and decarboxylase.
  • Structural Characterization: UV-Vis spectroscopy, HPLC, LC-MS, GC-MS, FT-IR, NMR.
  • Industrial Processes: Extraction, purification, separation, sterilization, pasteurization, atomization, evaporation, lyophilization.
  • Physicochemical Properties: Particle size, color parameters, viscosity, thickness, zeta potential, melting and boiling points, colloidal stability, water sorption isotherms, thermal properties.
  • Biochemistry: Antioxidant tests, microbiological assays, cell culture, cytotoxicity, genotoxicity, biocompatibility, polymer chemistry, food analysis.
  • Technical Skills: Expertise with various analytical instruments and techniques, including FT-IR, NMR, HPLC, LC-MS, SEM, TEM, and many others.
  • Statistical Analysis: ANOVA, Duncanā€™s Multiple Range tests.
  • Certifications: Management, Biotechnology, Life Cycle Analysis (SimaPro).

šŸŒ Language and Computer Proficiency

  • Languages:
    • French (Fluent)
    • English (Fluent)
    • Arabic (Native)
  • Computer Skills:
    • Microsoft Office (Word, Excel, PowerPoint)

This summary encapsulates the academic and professional journey of Abdulhadi ALJAWISH, emphasizing his vast experience in biotechnological processes, food science, and enzymatic applications.

 

šŸ“ŠšŸ”¬Notable Publication:

 

  • Bioprocesses for the Biodiesel Production from Waste Oils and Valorization of Glycerol
    • Authors: Decarpigny, C., Aljawish, A., His, C., Millares, M., Froidevaux, R.
    • Journal: Energies
    • Year: 2022

 

  • Green synthesis of glyco-phenol by enzymatic coupling between ferulic acid and glucosamine: An ecofriendly procedure
    • Authors: Aljawish, A., Chevalot, I., Paris, C., Muniglia, L.
    • Journal: Biotechnology and Applied Biochemistry
    • Year: 2022

 

  • Enzymatic Oxidation of Ferulic Acid as a Way of Preparing New Derivatives
    • Authors: Aljawish, A., Chevalot, I., Paris, C., Muniglia, L.
    • Journal: BioTech
    • Year: 2022

 

  • Comparing the efficiency of extracting antioxidant polyphenols from spent coffee grounds using an innovative ultrasound-assisted extraction equipment versus conventional method
    • Authors: Beaudor, M., Vauchel, P., Pradal, D., Aljawish, A., Phalip, V.
    • Journal: Chemical Engineering and Processing – Process Intensification
    • Year: 2023

 

  • Synthesis and characterization of release agent from used cooking oil at the concrete/formwork interface
    • Authors: Libessart, L., Anceur, R., Djelal, C., Aljawish, A., Millares, M.
    • Journal: International Journal of Environmental Science and Technology
    • Year: 2023

Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

Posted on by Pencis

Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

University of Pisa & Institute for Informatics and Telematics (IIT-CNR) | Italy

Author Profile

Scopus

Google Scholar

šŸ§‘ā€šŸ”¬ Marcello Di Giammarco: Ph.D. Student in Biomedical Engineering

šŸŽ“ Education

Master in Biomedical Engineering
UniversitĆ  degli Studi 'Roma Tre', Rome, Italy
šŸ“œ Degree: 2nd level degree in Biomedical Engineering
šŸ“ˆ Final Mark: 104/110
šŸ“š Thesis: EEG Signal Processing Functional to the Description of Cortical Network in Patients with Acute Ischemic Stroke
šŸ“… 2018 - 2020

Bachelor in Electronic Engineering
UniversitĆ  degli Studi 'Roma Tre', Rome, Italy
šŸ“œ Degree: 1st level degree in Information Technology
šŸ“ˆ Final Mark: 88/110
šŸ“š Thesis: BCI - Brain Computer Interface for Communication and Rehabilitation
šŸ“… 2012 - 2017

šŸ’¼ Work Experience

Ph.D. Student in Information Engineering
UniversitĆ  di Pisa, Pisa, Italy
šŸ“… 11/2022 - Present

šŸ“šResponsibilities:

  • Research project 'Artificial Intelligence and Cybersecurity in Medical Sector'
  • Conducting doctoral courses and seminars
  • Co-supervisor for Medical Engineering students
  • Research activities, testing artificial networks for medical purposes
  • Publishing articles and presenting at conferences
  • PC member in KES 2024 and EIAB 2024
  • Final doctoral thesis: Personal research project

šŸŒŸCo-relator

UniversitĆ  degli Studi del Molise, CB, Italy
šŸ“… 02/2022 - Present

šŸ“œResponsibilities:

  • Co-supervisor for Medical Engineering students
  • Number of students supervised: 7
  • Skills acquired: Presenting topics to students, using platforms for remote interaction

šŸŒ Language Skills

Italian

  • Mother Tongue

English

  • Listening: C1
  • Reading: C1
  • Writing: C1
  • Spoken Interaction: C1
  • Spoken Production: C1

šŸ’» Digital Competences

  • Information and Data Literacy: Independent user
  • Communication and Collaboration: Independent user
  • Digital Content Creation: Basic user
  • Safety: Basic user
  • Problem-Solving: Independent user

šŸŒOffice Automation:

  • Office Suite: Advanced
  • Presentation Software: Advanced
  • Spreadsheets: Intermediate
  • Web Browser: Intermediate
  • Word Processors: Advanced

šŸ“±Computer Programming:

  • LaTeX: Intermediate
  • C++: Advanced
  • MATLAB: Advanced
  • Python: Intermediate

šŸ”¬Systems and Networks Management:

  • Network Architecture: Advanced
  • Operating Systems: Highly Specialized
  • Linux: Intermediate

šŸš— Driving Licence

  • Category B

šŸ… Additional Certifications

  • Corso Art.37: Lupi Estintori SRL, 2020-10-25
  • Corso di Primo Soccorso: Lupi Estintori SRL, 2020

šŸŽ“ Relevant Courses

  • English for Research Publication and Presentation Purposes: University of Pisa, 2023 (C1 Level)

 

šŸ“ŠšŸ”¬Notable Publication:

 

  • Diabetic Retinopathy Detection and Diagnosis by Means of Robust and Explainable Convolutional Neural Networks
    • Authors: Mercaldo, F., Di Giammarco, M., Apicella, A., Martinelli, F., Santone, A.
    • Journal: Neural Computing and Applications
    • Year: 2023

 

  • Explainable Deep Learning for Alzheimer Disease Classification and Localisation
    • Authors: Di Giammarco, M., Iadarola, G., Martinelli, F., Ravelli, F., Santone, A.
    • Journal: Communications in Computer and Information Science
    • Year: 2022

 

  • High Grade Brain Cancer Segmentation by Means of Deep Learning
    • Authors: Di Giammarco, M., Martinelli, F., Mercaldo, F., Santone, A.
    • Journal: Procedia Computer Science
    • Year: 2022

 

  • Deep Learning for Heartbeat Phonocardiogram Signals Explainable Classification
    • Authors: Cesarelli, M., Di Giammarco, M., Iadarola, G., Mercaldo, F., Santone, A.
    • Journal: Proceedings - IEEE 22nd International Conference on Bioinformatics and Bioengineering, BIBE 2022
    • Year: 2022

 

  • Explainable Deep Learning Methodologies for Biomedical Images Classification
    • Authors: Di Giammarco, M., Mercaldo, F., Martinelli, F., Santone, A.
    • Journal: Proceedings - International Conference on Distributed Computing Systems, 2022
    • Year: 2022

Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Posted on by Pencis

Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Nankai University | China

Author Profile

Scopus

Orcid ID

šŸ“š Prof. Tao Sun: Innovator in Oncology and Drug Development

šŸŽ“Position:

  • Professor and Doctoral Supervisor, College of Pharmacy, Nankai University, China šŸŽ“

šŸŒŸTitles and Awards:

  • National Youth Talent šŸŒŸ
  • Winner of the Tianjin Distinguished Youth Scholar šŸ†

šŸ”¬Research Focus:

  • Molecular mechanisms of malignant tumors šŸ§¬
  • Drug development šŸ’Š
  • Pharmacology šŸ”¬

šŸ“„Publications:

  • Over 40 papers in prestigious journals, including Advanced Materials, Science Translational Medicine, Hepatology, and Cancer Research, as the first or corresponding author. šŸ“„

šŸ“œPatents and Approvals:

  • More than 20 authorized patents šŸ“œ
  • 3 new drug clinical approvals āœ…

šŸ§ŖResearch Leadership:

  • Principal investigator of 8 major scientific research projects, including Major National Science and Technology Projects and general projects of the National Natural Science Foundation of China. šŸ§Ŗ

šŸ„‡Achievements in Education:

  • Instructed students to win the Gold Award in the China International College Students’ “Internet+” Innovation and Entrepreneurship Competition šŸ„‡
  • Recipient of the “Top Ten Award of Scholarly Mentor and Beneficial Friend” at Nankai University šŸŽ–
  • Second Prize winner of the Nankai University Teaching Achievement Award šŸ„ˆ

šŸ’ŠSummary:

  • Prof. Tao Sun is a distinguished scholar and innovator at Nankai University, renowned for his contributions to oncology, drug development, and pharmacology. His prolific research, numerous patents, and leadership in significant scientific projects underscore his impact in the field. As an educator, he has been instrumental in guiding students to achieve excellence, earning recognition for his mentorship and teaching achievements. šŸŒŸšŸ”¬šŸ’Š

 

šŸ“ŠšŸ”¬Notable Publication:

 

Interaction between laminin-5Ī³2 and integrin Ī²1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1

  • Authors: Cai, S., Bi, Z., Bai, Y., … Liu, H., Yang, C.
    Journal: Frontiers in Oncology
  • Year: 2020

 

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

  • Authors: Meng, J., Han, J., Wang, X., … Liu, H., Sun, T.
    Journal: Pharmacological Research
  • Year: 2023

 

Correction: Interaction between laminin-5Ī³2 and integrin Ī²1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma

  • Authors: Han, J., Meng, J., Chen, S., … Sun, T., Yang, C.
    Journal: Cancer Research
  • Year: 2019

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

University of Health Sciences, Izmir | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

  • Assoc Prof Dr. ElƧin Aydın’s academic journey began with a strong foundation in medical sciences. She pursued her education with a focus on radiology, demonstrating a keen interest in the diagnostic and therapeutic applications of imaging technologies. Her early academic pursuits laid the groundwork for her specialization in abdominal and genitourinary radiology.

PROFESSIONAL ENDEAVORS

  • Dr. Aydın is currently affiliated with the University of Health Sciences in Izmir, Turkey, and works at Izmir City Hospital. Her professional endeavors have been marked by a commitment to clinical excellence and academic rigor. She has been an active member of prestigious organizations such as the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Congress of Radiology (ECR), and the European Society of Urogenital Radiology (ESUR).

CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Aydın has made significant contributions to the field of radiology through her research and clinical work. She has published 14 original articles in SCI-EXP indexed journals and authored 4 case studies, highlighting her expertise in abdominal and genitourinary radiology. Her research focuses on the diagnostic accuracy and clinical applications of imaging techniques in these areas, aiming to improve patient outcomes through advanced radiological practices.

IMPACT AND INFLUENCE

  • Through her scholarly publications and clinical practice, Dr. Aydın has had a considerable impact on the field of radiology. Her work is frequently cited by peers, reflecting the influence of her research on contemporary radiological practices. Her involvement in ESGAR, ECR, and ESUR underscores her influence within the radiological community, where she contributes to the advancement of knowledge and practice standards.

ACADEMIC CITATIONS

  • Dr. Aydın’s research has garnered significant academic attention, with numerous citations in prominent radiological journals. Her studies on abdominal and genitourinary radiology are referenced by other researchers and clinicians, indicating the high regard in which her work is held. This academic recognition is a testament to the quality and relevance of her research contributions.

LEGACY AND FUTURE CONTRIBUTIONS ON ENDOMETRIUM CANCER

  • Dr. Aydın’s legacy in the field of radiology is characterized by her dedication to advancing medical imaging and improving patient care. Looking ahead, she is poised to continue her impactful research and clinical work, with a focus on innovative imaging techniques and their applications in abdominal and genitourinary radiology. Her future contributions are expected to further enhance the understanding and practice of radiology, benefiting both the medical community and patients.

OTHER IMPORTANT TOPICS

TEACHING AND MENTORSHIP

  • In addition to her research and clinical responsibilities, Dr. Aydın is deeply committed to teaching and mentoring the next generation of radiologists. Her role at the University of Health Sciences allows her to shape the education and training of medical students and residents, ensuring the continued growth and development of the field.

COLLABORATIVE PROJECTS

  • Dr. Aydın actively engages in collaborative projects with other institutions and researchers. These collaborations enable the sharing of knowledge and expertise, fostering innovation and improving radiological practices globally. Her collaborative efforts have resulted in several joint publications and research initiatives.

PROFESSIONAL DEVELOPMENT

  • Continuous professional development is a cornerstone of Dr. Aydın’s career. She regularly participates in international conferences, workshops, and training programs to stay abreast of the latest advancements in radiology. This commitment to lifelong learning ensures that she remains at the forefront of her field, providing the highest standard of care to her patients.

 

šŸ“ŠšŸ”¬Notable Publication:

Extrapulmonary Tuberculosis: An Old but Resurgent Problem

  • Authors: Baykan, A.H., Sayiner, H.S., Aydin, E., Inan, I., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2022

 

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

  • Authors: Altunisik, E., Baykan, A.H., Sahin, S., Aydin, E., Erturk, S.M.
    Journal: American Journal of Neuroradiology
  • Year: 2021

 

Primary Breast Tuberculosis: Imaging Findings of a Rare Disease

  • Authors: Baykan, A.H., Sayiner, H.S., Inan, I., Aydin, E., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2021

 

Reliability of Real-Time Sonoelastography in the Diagnosis of Supraspinatus Tendinopathy

  • Authors: Aydın, E., Sƶylev, G.Ɩ., Muratlı, S.K., Tekindal, M.A., Ağıldere, M.
    Journal: Ultrasound Quarterly
  • Year: 2021

 

Optical Coherence Tomography-Angiography Findings of Prediabetic Patients

  • Authors: Emre, S., Altin, C., Ulusoy, M.O., Aydin, E.
    Journal: Oman Journal of Ophthalmology
  • Year: 2024

Dr. Stavros Melemenidis | Micrometastases | Best Researcher Award

Posted on by Pencis

Dr. Stavros Melemenidis | Micrometastases | Best Researcher Award

Stanford University School of Medicine | United States

Author Profile

Scopus

Orcid id

šŸ“š Biography: Dr. Stavros Melemenidis

šŸŽ“ Education

  • DPhil in Radiation Biology – University of Oxford, Dept. Radiation Oncology, Oxford, UK (2010-2015)
    • Mentors: Prof. Nicola Sibson, Prof. Ruth Muschel
    • Thesis: Development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis
  • M.Sc. in Radiation Biology – University of Oxford, Dept. Radiation Oncology, Oxford, UK (2009-2010)
  • M.Sc. in Radiometrics – University of Liverpool, Dept. Physics, Liverpool, UK (2008-2009)
  • B.Sc. in Physics: Medical Applications – University of Liverpool, Dept. Physics, Liverpool, UK (2005-2008)
  • A.Eng. in PC Systems and Peripheral Equipment – IIEK Neapoleos, Technical College, Thessaloniki, Greece (1998-2000)
  • Cert. Medical Physics – UCLA, Dept. Radiation Oncology, Los Angeles, CA, USA (2022-2023)

šŸ¢ Current Position

  • Director of Pre-clinical Radiotherapy – Dept. of Radiation Oncology, Stanford University (Jan 2023-present)
  • Research Scientist – Div. of Radiation Therapy, Stanford University (Feb 2020-present)

šŸ”¬ Research Experience & Skills

  • Stanford University, Dept. Radiation Oncology, Stanford, CA
    • Director of Pre-clinical Radiotherapy Core (Jun 2023-present)
      • Calibration of preclinical orthovoltage irradiators
      • Monthly and annual quality checks for dosimetric consistency
      • Innovation in animal radiation shielding via 3D design and additive manufacturing
    • Basic Life Research Scientist at Div. of Radiation Therapy (Jun 2020-present)
      • Pioneering preclinical ultra-high dose-rate (FLASH) irradiation experiments
      • Specializing in 3D-designed radiation shielding for animal safety
      • Expertise in dosimetry using radiochromic film and ion chambers
      • Development of animal models involving tumor implantation and microsurgical techniques
    • Postdoctoral Fellow (Feb 2016-Jun 2020)
      • Advisor: Edward E. Graves
      • Led development of in vivo mouse tumor models integrating imaging, radiotherapy, and immunotherapy
      • Specialized in ultrasound-guided injection techniques
      • Conducted research into immune cell migration with a focus on macrophage imaging
      • Evaluated radioprotective strategies for healthy tissue through drug development
    • Postdoctoral Fellow at University of Oxford, Dept. Radiation Oncology (Jan 2015-Sep 2015)
      • Advisor: Nicola R. Sibson
      • Designed and evaluated innovative imaging probes for metastasis detection and angiogenesis visualization
      • Developed dual MRI/PET probe for metastasis and MRI probe for angiogenesis
      • Managed international research collaboration with Duke University

šŸ“œ Selected Publications

  • In vivo PET detection of lung micrometastasis by targeting endothelial VCAM-1. Int J Mol Sci, 2024.
  • Multi-institutional audit of FLASH and conventional dosimetry with a 3D-printed anatomically realistic mouse phantom. Int J Radiat Oncol Biol Phys, 2023.
  • Exploring deep learning for estimating the isoeffective dose of FLASH irradiation from mouse intestinal histological images. J Radiat Oncol Biol Phys, 2023.
  • Human enteroids as a tool to study conventional and ultra-high dose rate radiation. Integr Biol (Camb), 2023.
  • Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. J Clin Invest, 2023.

šŸ† Awards & Honors

  • Recognition of Excellent Research: Aegean Conferences: 12th International Conference on Complement Therapeutics, Rhodes, Greece, 2019
  • Poster Prize: Aegean Conferences: 3rd International Conference for Tumor Microenvironment and Cellular Stress, Greece, Mykonos, 2014

šŸ—£ļø Conference Presentations

  • Oral Presentation: Demonstrating FLASH effectiveness against CONV dose rates, 34th ACRO Summit, Orlando, FL, March 2024
  • Poster Presentation: Anatomically Realistic 3D Printed Mouse Phantom for Multi-Institutional Benchmarking of FLASH and CONV Irradiation, 65th ASTRO Annual Meeting San Diego, USA, Oct 2023

šŸ“ž References

  • Prof. Billy W Loo Jr: Professor of Radiation Oncology (Radiation Therapy), Stanford University School of Medicine
  • Prof. Edward E Graves: Associate Professor of Radiation Oncology and Director of Molecular Imaging Program, Stanford University School of Medicine
  • Prof. Frederick M Dirbas: Associate Professor of Surgery (General Surgery), Stanford University School of Medicine

Dr. Stavros Melemenidis is a distinguished figure in radiation oncology, with a profound impact on preclinical radiotherapy and FLASH irradiation research. His contributions to innovative imaging techniques and his dedication to advancing cancer treatment methodologies are reflected in his extensive publication record and numerous accolades.

šŸ“ŠšŸ”¬Notable Publication:

 

 

 

 

Prof. R. StephanieHuang – Oncology and Precision Medicine – Best Researcher AwardĀ 

Posted on by Pencis

Prof. R. StephanieHuang - Oncology and Precision Medicine - Best Researcher AwardĀ 

University Of Minnesota - Minneapolis, MN - United States

Author Profile

ScopusĀ 

Orcid

Early Academic Pursuits

Dr. Rong Stephanie Huang's academic journey began with her pursuit of pharmacology at the University of Minnesota, where she eventually earned the title of Distinguished McKnight University Professor. Her early academic pursuits laid the foundation for her distinguished career in the field.

Professional Endeavors

Throughout her career, Dr. Huang has held prestigious academic appointments, including her current position in the Department of Experimental and Clinical Pharmacology at the University of Minnesota. Her commitment to advancing pharmacology is evident in her leadership roles and contributions to various professional societies.

Contributions and Research Focus on Oncology and Precision Medicine

Dr. Huang's research primarily focuses on personalized and precision medicine, particularly in oncology. Her work aims to tailor treatments to individual patients by understanding the genetic and molecular mechanisms underlying cancer progression. This research has significant implications for improving patient outcomes in cancer treatment.

Impact and Influence

As a respected leader in pharmacology, Dr. Huang's influence extends beyond her research. Her leadership roles in organizations such as the International Pharmaceutical Federation (FIP) highlight her dedication to advancing the field on a global scale. Her contributions have shaped the landscape of personalized medicine and oncology research.

Academic Citations

Dr. Huang's research has garnered substantial attention within the academic community, evidenced by the numerous citations her work has received. Her findings have contributed to advancing knowledge in pharmacology, particularly in the realm of personalized medicine and cancer research.

Legacy and Future Contributions

Dr. Huang's legacy is characterized by her significant contributions to pharmacology and personalized medicine. Her ongoing leadership roles and mentorship efforts ensure that her impact will endure for future generations of pharmacologists. As she continues her research and advocacy, Dr. Huang will undoubtedly leave a lasting legacy in the field.

Notable Publications

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis.

Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma.

Integration of pan-cancer cell line and single-cell transcriptomic profiles enables inference of therapeutic vulnerabilities in heterogeneous tumors.

A review of computational methods for predicting cancer drug response at the single-cell level through integration with bulk RNAseq data.

 

 

 

Ms. Hao Li – Tumor Immunology – Young Scientist Award

Posted on by Pencis

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.Ā  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)